MedDataX Logo

Multicenter Database of Patients With Germ Cell Tumor

NCT ID: NCT02863003

Last Updated: 2021-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1315 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-09-30

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective and prospective cohort of patients with germ cell tumor in treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to create a multicenter database in order to characterize epidemiologically and clinicopathologically patients with germ cell tumor and evaluate the prognosis and clinical outcomes during cancer treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasms, Germ Cell and Embryonal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male patients with diagnosis of testicular, retroperitoneum or mediastinal primary tumor.
* Histological confirmation of germ cell tumor or clinical condition based on the elevation of tumor markers (AFP, HCG e/ou DHL) associated to testicular mass or/and retroperitoneal lymphnode enlargement or/and mediastinal mass.
* Medical records of the disease and treatment

Exclusion Criteria

* Female patients diagnosed with ovary germ cell tumor
* Male patients diagnosed with germ cell tumor in other locations.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Latin American Cooperative Oncology Group

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gustavo Werutsky, MD

Role: STUDY_DIRECTOR

Latin American Cooperative Oncology Group

Diogo Bastos, MD

Role: PRINCIPAL_INVESTIGATOR

Instituto do Cancer do Estado de São Paulo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CPO - Pucrs

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Israelita Albert Einstein

São Paulo, , Brazil

Site Status

Hospital São José

São Paulo, , Brazil

Site Status

ICESP

São Paulo, , Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LACOG 0515

Identifier Type: -

Identifier Source: org_study_id